Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SE & CO. KGAA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 2 0043 0654 2243 2433 243-
Enterprise Value (EV)1 2 2833 5054 7043 7553 6683 612
P/E ratio 23,6x42,8x56,1x40,9x34,1x28,5x
Yield 1,24%0,78%0,64%0,92%0,99%1,10%
Capitalization / Revenue 2,80x4,11x5,04x3,17x3,01x2,87x
EV / Revenue 3,19x4,70x5,62x3,67x3,40x3,20x
EV / EBITDA 12,5x19,7x22,5x16,8x14,7x13,2x
Price to Book 7,35x11,9x6,62x4,92x4,63x4,19x
Nbr of stocks (in thousands) 49 55648 07153 73552 64752 647-
Reference price (EUR) 40,463,878,661,661,661,6
Announcement Date 02/04/201902/05/202002/04/2021---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 7177468371 0221 0781 130
EBITDA1 182178209224249274
Operating profit (EBIT)1 140116134134159181
Operating Margin 19,6%15,5%16,0%13,1%14,7%16,0%
Pre-Tax Profit (EBT)1 127109111120138165
Net income1 86,273,773,080,696,6116
Net margin 12,0%9,88%8,71%7,89%8,96%10,2%
EPS2 1,711,491,401,511,812,17
Dividend per Share2 0,500,500,500,570,610,68
Announcement Date 02/04/201902/05/202002/04/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 229241276283260255
EBITDA1 47,050,769,565,057,260,8
Operating profit (EBIT)1 17,526,242,026,933,037,0
Operating Margin 7,66%10,9%15,2%9,50%12,7%14,5%
Pre-Tax Profit (EBT)1 -24,9-39,033,037,0
Net income1 -17,228,421,324,026,0
Net margin -7,13%10,3%7,51%9,23%10,2%
EPS2 -0,310,510,520,450,50
Dividend per Share ------
Announcement Date 05/06/202108/05/202111/04/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 279440480512425369
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,53x2,47x2,30x2,29x1,71x1,35x
Free Cash Flow1 96,095,894,9111111131
ROE (Net Profit / Equities) 34,4%28,3%21,9%15,5%16,5%17,5%
Shareholders' equity1 251260333519586661
ROA (Net Profit / Asset) 10,3%7,69%7,50%5,00%--
Assets1 8379589731 612--
Book Value Per Share2 5,515,3511,912,513,314,7
Cash Flow per Share2 2,732,242,903,263,153,62
Capex1 40,443,755,173,966,067,6
Capex / Sales 5,63%5,86%6,58%7,23%6,12%5,98%
Announcement Date 02/04/201902/05/202002/04/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Key data
Capitalization (EUR) 3 243 045 097
Capitalization (USD) 3 704 220 556
Net sales (EUR) 837 259 000
Net sales (USD) 954 550 613
Number of employees 8 079
Sales / Employee (EUR) 103 634
Sales / Employee (USD) 118 152
Avg. Exchange 20 sessions (EUR) 5 258 828
Avg. Exchange 20 sessions (USD) 5 995 537
Average Daily Capital Traded 0,16%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA